Photos: P&G Voluntarily Recalls Specific Lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom
19th November 2009 CINCINNATI, November 19 /PRNewswire/ -- The Procter & Gamble Company (NYSE: PG) announced today it is voluntarily
recalling three lots of its Vicks Sinex nasal spray in three countries: the
United...
Medicines Top Counterfeit Concern List in Europe - Consumers Call for Tougher Safety Measures
19th November 2009 LONDON, November 19 /PRNewswire/ -- Research published today examining consumer opinions on counterfeit drugs
reveals that five per cent of consumers across five European countries
suspect they have...
VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
19th November 2009 SAN DIEGO, November 19 /PRNewswire/ -- Accumetrics, Inc., developer of the VerifyNow System, the first
point-of-care method for measuring platelet reactivity, announces that its
market-leading...
Visage Imaging Signs University of Chicago
19th November 2009 ANDOVER, Massachusetts, November 19 /PRNewswire/ -- Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd.
(ASX: PME), announced today it has installed their Visage CS thin client...
Contact Centre Services to Take Off in Nigeria by 2015, Finds Frost & Sullivan
19th November 2009 CAPE TOWN, South Africa, November 19 /PRNewswire/ -- Despite industry challenges, the rising consumer demand from developing
industry sectors will drive exponential growth in the Nigerian contact...
Menicon to Acquire David Thomas Contact Lenses Ltd., Major U.K. Custom Lens Manufacturer
19th November 2009 NAGOYA, Japan, November 19 /PRNewswire/ -- Menicon Co., Ltd. (Menicon) and David Thomas Contact Lenses Ltd. (DTCL)
announced on November 19 that the two companies reached agreement on November
16,...
Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products
18th November 2009 IRVINE, California, November 18 /PRNewswire/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and
Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that
Lyon,...
/C O R R E C T I O N -- Teva UK Ltd/
18th November 2009 LEEDS, England, November 18 /PRNewswire/ -- In the news release, "Teva Launches TevaGrastim(R) (filgrastim)" issued on
18 Nov 2009 07:00 GMT, by Teva UK Ltd over PR Newswire, due to an omission...
Scientific Pioneer Lectures on AcceleDent Science in Key United Kingdom Orthodontic Venues
18th November 2009 HOUSTON, November 18 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System
(http://www.acceledent.com/), which is an acceleration device to enhance
orthodontics,...
Health Robotics Announces Worldwide Launch of the "i.v. Room of the Future" Concept at Las Vegas' ASHP
18th November 2009 BOZEN, Italy, November 18 /PRNewswire/ -- Health Robotics today announced the worldwide presentation and launch of
its revolutionary vision for "The i.v. Room of the Future" at the American
Society...
Frost & Sullivan: The North American and Western European Biopesticides Markets Will Grow Strong Thanks to Chemical-free Crops
18th November 2009 LONDON, November 18 /PRNewswire/ -- The biopesticides market in Western Europe and North America is growing
strongly. The increasing demand for chemical-free crops, paralleled by the
expansion of...
/C O R R E C T I O N -- Education for Health/
18th November 2009 LONDON, November 18 /PRNewswire/ -- In the news release, "Mainstay of the Global Workforce - 40-65 Year Olds
- Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)" issued on 18
Nov 2009...
Apieron Alleges Evidence Shows Aerocrine Inventors Withheld Prior Art Information from Patent Office
18th November 2009 MENLO PARK, California, November 18 /PRNewswire/ -- Apieron, Inc. has asked the court presiding over its patent suit against
Aerocrine, Inc. to allow it to raise additional grounds for...
Hard To Treat Diseases (HTDS) Mellow Hope's H1N1 Influenza A Vaccine Successful Registration in Chile
18th November 2009 SHENZHEN, China, November 18 /PRNewswire/ -- Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China
subsidiary Mellow Hope announce that they have acquired a Registration...
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
18th November 2009 GOTHENBURG, Sweden, November 18 /PRNewswire/ -- Albireo today announced the completion of a phase 1b study showing a
favourable tolerability and safety profile of A3309 in patients with chronic...
Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
18th November 2009 SALT LAKE CITY, November 18 /PRNewswire/ -- Booth - A78/Hall 10 - Varian Medical Systems, Inc. (NYSE: VAR), a premier
supplier of X-ray tubes and flat panel digital image detectors, will exhibit
its...
Teva Launches TevaGrastim(R) (filgrastim)
18th November 2009 LEEDS, England, November 18 /PRNewswire/ -- Teva UK Limited has signalled its commitment to developing biosimilar
medicines by entering the G-CSF* therapy area. The launch of its proprietary
version...
Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)
18th November 2009 LONDON, November 18 /PRNewswire/ -- COPD Uncovered, a new report issued today reveals for the first time that
people between the ages of 40 to 65 are emerging as the new face of this
disease....
AMT Provides Business Update for the Third Quarter 2009
18th November 2009 AMSTERDAM, November 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in
the field of human gene therapy, today provides its non-audited business
update in...
New H1N1 Flu Test Available Now - On Display At MEDICA 2009
18th November 2009 DÃSSELDORF, Germany, November 18 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider
of diagnostic testing, information and services, today announced that...
Video: Crestor(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of Jupiter Study
17th November 2009 ORLANDO, Florida, November 17 /PRNewswire/ -- JUPITER, which used CRESTOR 20 mg, is the first statin study to
demonstrate a reduction in the risk of cardiovascular (CV) events in women
without...
FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
17th November 2009 LAKE ZURICH, Illinois, November 17 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving
blood collection, separation, safety and availability, announced today...
Lamborghini Chooses Poker Pro Magazine as Official Sponsor of Celebrity Poker Event
17th November 2009 DELRAY BEACH, Florida, November 17 /PRNewswire/ -- Lamborghini Travels has chosen Poker Pro as the official magazine sponsor
of the star-studded celebrity poker tournament in Los Angeles...
Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE
17th November 2009 PLEASANTON, California, November 17 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based
mechanical circulatory support therapies to save, support and restore...
LightSleeper(R), a Bedside Electronic Sleep Aid is Hotly Tipped to be a Ground-Breaking Solution for Anyone who has Problems Sleeping
17th November 2009 LONDON, November 17 /PRNewswire/ -- LightSleeper projects a light onto the ceiling in a controlled, circular
motion. Following it with your eyes encourages the mind to relax into a good
night's...
New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications
17th November 2009 LEIDEN, The Netherlands, November 17 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a
consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and
Maastricht University to...
Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries
17th November 2009 HAYWARD, California, November 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today
announced that its readerless CD4 point-of-care (POC) technology was selected
by...
US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine
17th November 2009 KVISTGÃ
RD, Denmark, November 17 /PRNewswire/ -- Bavarian Nordic A/S (OMX: BAVA) announced today that BARDA (Biomedical
Advanced Research and Development Authority) has awarded a new contract...
Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
17th November 2009 SHENZHEN, China, November 17 /PRNewswire/ -- Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China
subsidiary Mellow Hope announce that its MMR vaccine (Measles, Mumps and
Rubella...
Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial
16th November 2009 ORLANDO, Florida, November 16 /PRNewswire/ -- Abbott (NYSE: ABT) today announced three-year data from the first 30
patients in the first phase of the ABSORB clinical trial, demonstrating that
its...
Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibrillation
16th November 2009 PARIS, November 16 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
the launch of the RealiseAF registry (Real Life global Survey Evaluating
patients with Atrial...
ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic TB-403 in Patients With Advanced Solid Tumours
16th November 2009 LEUVEN, Belgium and LUND, Sweden, November 16 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent
International AB (OMXS: BINV) today announced positive results from a Phase...
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
16th November 2009 JAMAICA PLAIN, Massachusetts, November 16 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced it will give a presentation today
at the AACR-NCI-EORTC International Conference Molecular Targets and...
Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
16th November 2009 INGELHEIM, Germany, November 16 /PRNewswire/ -- Data from pooled, pivotal Phase III clinical trials demonstrate that
flibanserin 100mg taken once daily at bedtime significantly increased the
number...
Medical Doctors Confirm "Divine Healing" Cases at the 6th International Christian Medical Conference
16th November 2009 KIEV, Ukraine, November 16 /PRNewswire/ -- The 6th International Christian Medical Conference was held at the
President Hotel on October 30 and 31, 2009 under the auspices of Ukraine
Organizing...
Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market
16th November 2009 LONDON, November 16 /PRNewswire/ -- The "omics" revolution of the last decade has ensured that the field of
biomarker research will test the frontiers of biomedical research in the
coming years. New...
ALK Announces Landmark Asthma Prevention Trial
16th November 2009 COPENHAGEN, Denmark, November 16 /PRNewswire/ -- GAP will be the largest ever trial to investigate the asthma preventive
effect of specific immunotherapy in children (5-12 years old) with...
Concuity Announces Next-Generation Revenue Cycle Management Solution
16th November 2009 VERNON HILLS, Illinois and DUBLIN, November 16 /PRNewswire/ -- Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading
provider of Revenue Cycle Management technology and services,...
New Intra-Arrest Cooling Method May Save More Brains During Cardiac Arrest
15th November 2009 ORLANDO, Florida, November 15 /PRNewswire/ -- The first randomized intra-arrest cooling study performed using a novel
intra-nasal cooling method showed much faster and earlier cooling in...
First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes
15th November 2009 ORLANDO, Florida, November 15 /PRNewswire/ -- Results from the RecordAF registry (REgistry on Cardiac rhythm
disORDers assessing the control of Atrial Fibrillation), presented today at
the Scientific...
Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
15th November 2009 ORLANDO, Florida, November 15 /PRNewswire/ -- Results from a new study showed patients with type 2 diabetes mellitus
who also had coronary artery disease (CAD) and received a 60 mg loading dose
and...
/C O R R E C T I O N -- Scope Dental Professional Relations/
13th November 2009 LONDON, November 13 /PRNewswire/ -- In the news release, "Mouth London - Cancer Screening at Local Dental
Practice" issued on 13 Nov 2009 11:48 GMT, by Scope Dental Professional
Relations over PR...
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
13th November 2009 INDIANAPOLIS, November 13 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Steven M. Paul,
M.D., executive vice president, science and technology, and president, Lilly
Research...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
